Analysis of RAS oncogene mutations in human lymphoid malignancies - Wikidata - wikimedia - TriplyDB

Analysis of RAS oncogene mutations in human lymphoid malignancies

Analysis of RAS oncogene mutations in human lymphoid malignancies

http://www.wikidata.org/entity/Q24643802

about

Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas Guanosine triphosphatase stimulation of oncogenic Ras mutants Solution-based scanning for single-base alterations using a double-stranded DNA binding dye and fluorescence-melting profiles Anti-tumor effect of bisphosphonate (YM529) on non-small cell lung cancer cell lines.Synergistic effect of Bcl2, Myc and Ccnd1 transforms mouse primary B cells into malignant cells.Oncogene activation in human benign tumors of the skin (keratoacanthomas): is HRAS involved in differentiation as well as proliferation?Quantitation of mRNA by the polymerase chain reaction.Endogenous oncogenic Nras mutation initiates hematopoietic malignancies in a dose- and cell type-dependent manner.Therapeutic efficacy of prenylation inhibitors in the treatment of myeloid leukemia.Molecular characterization of primary mediastinal B cell lymphoma Western thymomas lack Epstein-Barr virus by Southern blotting analysis and by polymerase chain reaction.K-ras activation occurs frequently in mucinous adenocarcinomas and rarely in other common epithelial tumors of the human ovary Neoplasia of the ampulla of Vater. Ki-ras and p53 mutations Analysis of alterations of oncogenes and tumor suppressor genes in chronic lymphocytic leukemia.Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide.The proliferation of multiple myeloma colonies (MY-CFUc) in vitro is independent of prognosis and is not associated with mutated N- or K-ras alleles in human bone marrow aspirates.Targeting oncogenic Ras signaling in hematologic malignancies.Ras oncogene mutation in multiple myeloma Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas Detection of mutant Ha-ras genes in chemically initiated mouse skin epidermis before the development of benign tumors.Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia.Oncogene-directed alterations in cancer cell metabolism.p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.Molecular diagnosis of p53 mutations in gastric carcinoma by touch preparation.Tumor markers in human biopsy material.Dinaciclib Induces Anaphase Catastrophe in Lung Cancer Cells via Inhibition of Cyclin-Dependent Kinases 1 and 2.Aberrant expression of RasGRP1 cooperates with gain-of-function NOTCH1 mutations in T-cell leukemogenesis.Point mutation in codon 61 of N-RAS genes in human myeloma cell lines N- and K-ras oncogenes in plasma cell dyscrasias.Laboratory probing of oncogenes from human liquid and solid specimens as markers of exposure to toxicants.Analysis of methylation in the c-MYC gene in five human myeloma cell lines.Lack of association between N-ras gene mutations and clinical prognosis in Brazilian children with acute lymphoblastic leukemia.c-N-ras is activated infrequently in canine malignant lymphoma.Farnesyltransferase inhibitor BMS-214662 induces apoptosis in B-cell chronic lymphocytic leukemia cells.RAS pathway mutations as a predictive biomarker for treatment adaptation in pediatric B-cell precursor acute lymphoblastic leukemia.Molecular characterization of disseminated pilocytic astrocytomas.Comparative analysis of ras proto-oncogene mutations in selected mammalian tumors.Deubiquitinase USP18 Loss Mislocalizes and Destabilizes KRAS in Lung Cancer.RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.

P2860

Q24561494-5D1065E4-0CAC-492F-A01C-631130BE508A Q24657474-B64A2874-48E4-49E0-B90C-BBE386A971E8 Q27618496-B9F97823-121A-4355-B97B-8FECDD95C650 Q28350687-20E1D599-0570-44F8-8EC2-5D47CA2AB6DE Q33269187-C329F2C9-E275-4CC5-B0A3-12EB14D39D77 Q33909737-7B35C740-8F62-4B71-AC00-040A76A98C27 Q34298327-5B57AD8B-8439-4052-8F56-EFC6A556BE7B Q34324828-51E4A7CA-E101-443C-BB57-07BE98BF8915 Q35112241-F75802EF-87BC-427E-9F57-FD597C439709 Q35186888-AF3EC389-34CC-4C5B-BFFB-D45B434CAA77 Q35773944-06B34EB7-BF13-46AE-9216-FA43DE406B83 Q35811735-BF1A91D3-EDF8-44CB-A2A7-58C89BC365F4 Q35831077-314FAF17-A769-457B-838E-31C631579AA1 Q35832722-B4157441-C4EF-4F99-9D16-1AEB49660FF2 Q35834161-DA43F334-5B77-4956-81FA-66D040BEC954 Q35881223-F7F90FF6-A16B-402C-AE0D-C268A0E23A74 Q36080374-655EB75A-972B-4E2D-BC0D-73F5DDDD8970 Q36352506-70C1F015-57E4-4DE9-B5BE-B857486F1AB6 Q36356976-4B6A9F74-4E7B-470F-86B3-CA8D7892EEB2 Q36693797-0DC6E3B4-0419-477A-B2BF-4E268E6072D8 Q37108465-2EA444E9-BDBB-4C0D-A8CA-24F8C633DD15 Q37322911-1CE7EEC8-FD18-47E1-A23C-2F628B3C488D Q37395416-B870D9CD-CBF8-4C08-8CC7-6F7B4CCE283A Q37535238-E861F125-96ED-445C-B0A5-32114C6EC37C Q38362385-4AABFBB8-D787-4A5F-9D13-B4F38264C57B Q38729642-9AA1B66C-0CDD-496F-9110-8D2CC85A9E5D Q38734002-3A1C1595-F953-481B-BC01-846278ED08F8 Q39437389-7E9EFB0B-7DFC-4FB4-AB7B-F88E8DFA3D2A Q40538774-A223B67A-DE89-4CFA-8577-3017A411BA1F Q40594604-D48A1C60-E7A4-4D11-B08C-BD12737624C9 Q41188296-1F5DD9BA-2896-4FB7-84B3-EEFA6F3E8A98 Q41696394-343B5D10-3C82-4FB3-A183-83F0316D59CE Q43792826-47AACBA6-8794-453E-B033-B7D7187528D2 Q44996789-C3B9F767-5407-471B-9B6C-ED47A5126180 Q45051064-47B83E9D-10AB-4EA3-81F7-62FB54D33929 Q47875530-E31648F7-03A2-43E5-9B42-50ECD95A7FBE Q48124187-960A9615-EE64-49B1-BFF8-51D93C4280EC Q50759089-04E0FEB2-D300-4AC2-81C0-31AEBB69601D Q51119632-E10F3924-DFFC-4E32-B372-6741E2690CFE Q52002743-B8D0FF61-067F-4E65-8FD1-0DA2FDF72AB9

P2860

Analysis of RAS oncogene mutations in human lymphoid malignancies

http://www.wikidata.org/entity/Q24643802

description

1988 nî lūn-bûn

@nan

1988 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1988 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

name

Analysis of RAS oncogene mutations in human lymphoid malignancies

@ast

Analysis of RAS oncogene mutations in human lymphoid malignancies

@en

Analysis of RAS oncogene mutations in human lymphoid malignancies

@nl

type

label

Analysis of RAS oncogene mutations in human lymphoid malignancies

@ast

Analysis of RAS oncogene mutations in human lymphoid malignancies

@en

Analysis of RAS oncogene mutations in human lymphoid malignancies

@nl

prefLabel

Analysis of RAS oncogene mutations in human lymphoid malignancies

@ast

Analysis of RAS oncogene mutations in human lymphoid malignancies

@en

Analysis of RAS oncogene mutations in human lymphoid malignancies

@nl

P1433

Q24643802-281537ED-465B-4948-AE5F-19A6FBC98B15

P1476

Q24643802-A746496D-8D68-40C9-8849-235F7FB40F0C

P2093

Q24643802-4651E55E-4880-4D8F-95A7-BB67CA82EB29

Q24643802-5296763C-56EB-43FE-A8DA-8D8ED85351E7

Q24643802-753EC009-83BF-4D17-B67A-E8F211CB25EE

Q24643802-9A968C9E-287E-47EA-AE58-970D0B8060F8

Q24643802-D33D8447-E92D-481F-8DB5-F5FCAB56BED2

P2860

Q24643802-01FBCD67-AB70-47BC-97C1-658877E9777B

Q24643802-1D3F2892-ED1B-496C-A26C-AF81F240B2D4

Q24643802-3121690F-9DB8-4F7C-97A8-5AD11A9605A9

Q24643802-3777282C-0B7B-4EC8-9E23-833E00DA57C0

Q24643802-42A3BAC9-518E-4750-BBCF-463174E1F884

Q24643802-4D6CC26D-3910-40C5-8776-4E767D675700

Q24643802-569611FD-34B0-413B-8920-97134C1E491A

Q24643802-5E17B993-8B66-4197-80BA-33C265253892

Q24643802-5FF248B0-2F41-49CD-A8B6-E1973C03A19B

Q24643802-6820626B-3537-4488-9048-9E0C288DA00B

P304

Q24643802-897C90A4-FF4D-463E-B668-71B0C36F52A8

P31

Q24643802-A3FD2B20-23B1-4BBF-A737-25AC57117CC1

P356

Q24643802-1ABE2115-E8F1-4560-A18E-CADC426CB7CE

P407

Q24643802-A0B7FD81-2D5A-4B9F-B1A5-44081FB70EF4

P433

Q24643802-FD125B39-18F9-4EB4-9D1E-9EF963937F48

P478

Q24643802-082BEFA2-4CDE-47C2-9854-9CCEBC0CB209

P577

Q24643802-74ACD659-C2D5-4ABF-BB85-C6FCB90A35D6

P5875

Q24643802-89DAB655-FE87-47FE-9D34-12D8C1D73445

P698

Q24643802-0EE6B33B-37EA-47B3-A52D-BED0ED90B93E

P932

Q24643802-70EE39C1-6A53-4684-8919-BB5257F150C1

P356

PNAS.85.23.9268

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Analysis of RAS oncogene mutations in human lymphoid malignancies

@en

P2093

A Greco

http://www.w3.org/2001/XMLSchema#string

A Neri

http://www.w3.org/2001/XMLSchema#string

D M Knowles

http://www.w3.org/2001/XMLSchema#string

F McCormick

http://www.w3.org/2001/XMLSchema#string

R Dalla-Favera

http://www.w3.org/2001/XMLSchema#string

P2860

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia

A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome

Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes

Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene.

Analysis of RAS gene mutations in acute myeloid leukemia by polymerase chain reaction and oligonucleotide probes.

Characterization of c-Ki-ras oncogene alleles by direct sequencing of enzymatically amplified DNA from carcinogen-induced tumors.

Concomitant K- and N-ras gene point mutations in clonal murine lymphoma

Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype.

P304

9268-72

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.85.23.9268

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

1988-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

20097789

http://www.w3.org/2001/XMLSchema#string

P698

3057505

http://www.w3.org/2001/XMLSchema#string

P932

282720

http://www.w3.org/2001/XMLSchema#string